The ceo when asked how much cash said after we retire the debt we will have $5M sometime next year.
Guess what? they have $5 M in debt. Sounds like a pump n dump to raise $10m to me, LOL
Matrixx's Johnson: Financial Outlook and Zicam Products Page 1/2
New York, Oct. 8, 2002 (Bloomberg) -- Carl Johnson, chief executive of
Matrixx Initiatives Inc., talks with Bloomberg's Ambre Brown Morley about the
company's financial outlook, marketing strategy and its Zicam line of cold and
allergy products. Matrixx changed its name from Gum Tech International Inc. in
June.
01:35 Matrixx's Zicam products; outlook for competition
01:00 Change in business focus and company name since June
01:07 Financial performance; profitability outlook; new products
01:59 Acquisition strategy; product development; advertising
01:22 Marketing strategy for Zicam line; cash position
01:00 Sales outlook; 2001 loss; full-year earnings outlook
For company information see MTXX <Equity> CN, BQ. For related news see the
following NI codes: HEA, DRG, MEDICAL, NP, COS, CORPFIN, CEO, ERN, EST, ADV,
US, NY, AZ. For more on the Bloomberg Forum see FORUM. For more Bloomberg
Multimedia reports see AV. -- Bloomberg Multimedia (609) 750-4455 (AK/EC)
Running time 8:03.
-0- (BN ) Oct/08/2002 18:59 GMT |
